DMKJ
IMVT icon

David M. Knott Jr’s Immunovant IMVT Stock Holding History

David M. Knott Jr’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-22,443
Closed -$384K – 90
2025
Q1 		$384K Sell
22,443
-69,557
-76% -$1.46M 0.18% 52
2024
Q4 		$2.28M Hold
92,000
– – 0.82% 19
2024
Q3 		$2.62M Buy
92,000
+500
+0.5% +$14.7K 0.92% 24
2024
Q2 		$2.42M Buy
91,500
+6,200
+7% +$176K 0.96% 21
2024
Q1 		$2.76M Buy
85,300
+83,815
+5,644% +$3.06M 0.97% 21
2023
Q4 		$63K Buy
+1,485
New +$54.6K 0.02% 70

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AGM
Alpine Global Management New York $615M AUM 34.28% 1-Year Est. Return

David M. Knott Jr's IMVT Position: Q2 2025 in Review

David M. Knott Jr sold out of Immunovant (IMVT) in Q2 2025, closing a stake of 22,443 shares — an estimated $384K sold.

David M. Knott Jr first reported a position in IMVT in Q4 2023 and held it in 6 quarters. The position peaked at $2.76M in Q1 2024. 168 funds tracked by Wall St. Rank hold IMVT as of Q2 2025.

  • David M. Knott Jr reported no remaining Immunovant position as of Q2 2025 after selling out during the quarter.
  • David M. Knott Jr sold 22,443 Immunovant shares in Q2 2025, an estimated $384K.
  • David M. Knott Jr first reported a position in Immunovant in Q4 2023 and held it in 6 quarters.
  • David M. Knott Jr's Immunovant position peaked at $2.76M in Q1 2024.
  • 168 funds tracked by Wall St. Rank held Immunovant as of Q2 2025.

Based on David M. Knott Jr's 13F filing for Q2 2025, filed 11 Aug 2025.